Diagnosis of Transthyretin Amyloid Cardiomyopathy

Abstract Transthyretin amyloid cardiomyopathy (ATTR-CM) continues to be an easily overlooked, life-threatening, yet treatable cause of heart failure. Furthermore, its elusive diagnosis leads to late or misdiagnosis. As therapeutic advancements such as tafamidis usher in a promising new era in the ma...

Full description

Bibliographic Details
Main Authors: Adam S. Hafeez, Anthony A. Bavry
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-04-01
Series:Cardiology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40119-020-00169-4